CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
CHARLESTON â The fourth week of Huntington and Cabell Countyâs opioid trial against three drug distributors was highlighted by an email showing McKesson Corp. employees cheering Appalachian trends shifting away from pills to illicit drugs in 2012.
The email was shared among McKesson employees, first by Tracey Jonas, director of regulatory processes, who shared a February 2012 article which said the DEA was seeing a sharp drop in Florida oxycodone.
Dave Gustin, a director of regulatory affairs, said pill users in Ohio and Kentucky were shifting to illicit drug use, such as heroin and meth. Jonas responded âGood . let them move to heroin and meth .we donât have to monitor that.â
1 of 2
The trial of the âBig Threeâ drug companies accused of fueling an opioid drug epidemic in Cabell County and the city of Huntington is taking place at the Robert C. Byrd U.S. Courthouse in Charleston.
Courtesy of the West Virginia Humanities Council
An email released Friday in the federal trial pitting Huntington and Cabell County against three drug distributors showed McKesson Corp. employees cheering trends that showed Appalachians were shifting away from
CHARLESTON — McKesson Corp. made its sales force the company’s “eyes and ears” against illegal drug diversion, all while giving them a chance to double their salaries for making sales,